DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 20 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +150.0% | 10,000 | +566.7% | 0.00% | – |
| Q3 2017 | $2,000 | -33.3% | 1,500 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +100.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Swift Run Capital | 2,348,017 | $1,014,000 | 0.88% |
| Signature Financial Management, Inc. | 12,350 | $5,000 | 0.00% |
| Virtu Financial LLC | 41,515 | $18,000 | 0.00% |
| Smithfield Trust Co | 2,052 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 894,732 | $386,000 | 0.00% |
| JOYN Advisors, Inc. | 1,740 | $1,000 | 0.00% |
| JANE STREET GROUP, LLC | 18,787 | $8,000 | 0.00% |
| St. Johns Investment Management Company, LLC | 23 | $0 | 0.00% |
| UBS Group AG | 31,096 | $13,000 | 0.00% |
| Advisor Group, Inc. | 4,370 | $2,000 | 0.00% |